November 20, 2026 · Tropical doctor · DOI: 10.1177/00494755261509008

Accuracy of Xpert MTB/XDR panel to detect antitubercular drug resistance in Indian children.

Listen to this summary

This study evaluated how well the Xpert MTB/XDR panel agrees with line probe assays (LPAs) and moxifloxacin phenotypic drug susceptibility testing (pDST), alongside Xpert MTB/RIF or Ultra, for detecting drug-resistant tuberculosis in Indian children. The authors found good concordance between Xpert MTB/XDR and LPAs, and they suggest the test could serve as a stand-alone tool to identify the type of drug-resistant TB and guide upfront second-line treatment.

Dhruv Gandhi, Shatakshi Garg, Sonal Patil, Dhruv Mamtora, Minnie Bodhanwala, Ira Shah

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play